Kelman Lazarov, Inc. Johnson & Johnson Transaction History

Kelman Lazarov, Inc.

$494 Million
Q2 2024

A detailed history of Kelman Lazarov, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Kelman Lazarov, Inc. holds 4,175 shares of JNJ stock, worth $669,210. This represents 0.12% of its overall portfolio holdings.

Number of Shares

4,175

Previous 4,258 1.95%

Holding current value

$669,210

Previous $673,000 9.36%

% of portfolio

0.12%

Previous 0.14%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$144.38 - $157.78 $11,983 - $13,095	-83 Reduced 1.95%	4,175 $610,000
Q1 2024 May 09, 2024	BUY	$155.22 - $162.74 $2,173 - $2,278	14 Added 0.33%	4,258 $673,000
Q4 2023 Feb 01, 2024	SELL	$145.6 - $158.88 $24,024 - $26,215	-165 Reduced 3.74%	4,244 $665,000
Q3 2023 Oct 30, 2023	BUY	$155.75 - $174.48 $44,233 - $49,552	284 Added 6.88%	4,409 $686,000
Q2 2023 Aug 04, 2023	BUY	$154.35 - $166.11 $23,306 - $25,082	151 Added 3.8%	4,125 $682,000
Q1 2023 May 04, 2023	BUY	$151.05 - $180.26 $3,172 - $3,785	21 Added 0.53%	3,974 $615,000
Q4 2022 Feb 06, 2023	SELL	$160.2 - $179.79 $63,278 - $71,017	-395 Reduced 9.08%	3,953 $698,000
Q3 2022 Oct 24, 2022	BUY	$161.33 - $179.52 $32,266 - $35,904	200 Added 4.82%	4,348 $710,000
Q2 2022 Aug 08, 2022	SELL	$168.19 - $186.01 $37,674 - $41,666	-224 Reduced 5.12%	4,148 $736,000
Q1 2022 May 10, 2022	SELL	$158.14 - $179.59 $7,906 - $8,979	-50 Reduced 1.13%	4,372 $775,000
Q4 2021 Feb 09, 2022	BUY	$155.93 - $173.01 $51,300 - $56,920	329 Added 8.04%	4,422 $756,000
Q3 2021 Nov 04, 2021	SELL	$161.5 - $179.47 $25,032 - $27,817	-155 Reduced 3.65%	4,093 $661,000
Q2 2021 Aug 10, 2021	SELL	$159.48 - $171.07 $36,680 - $39,346	-230 Reduced 5.14%	4,248 $700,000
Q4 2020 Feb 08, 2021	BUY	$137.11 - $157.38 $6,855 - $7,869	50 Added 1.13%	4,478 $705,000
Q3 2020 Nov 12, 2020	BUY	$140.38 - $153.83 $30,602 - $33,534	218 Added 5.18%	4,428 $659,000
Q2 2020 Jul 29, 2020	SELL	$128.81 - $155.51 $52,683 - $63,603	-409 Reduced 8.85%	4,210 $592,000
Q1 2020 Apr 27, 2020	SELL	$111.14 - $153.99 $18,893 - $26,178	-170 Reduced 3.55%	4,619 $606,000
Q4 2019 Jan 29, 2020	SELL	$127.5 - $146.44 $10,965 - $12,593	-86 Reduced 1.76%	4,789 $699,000
Q3 2019 Oct 15, 2019	SELL	$126.95 - $142.14 $21,327 - $23,879	-168 Reduced 3.33%	4,875 $631,000
Q1 2019 May 08, 2019	BUY	$125.72 - $139.79 $70,654 - $78,561	562 Added 12.54%	5,043 $705,000
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $24,316 - $28,576	-200 Reduced 4.27%	4,481 $619,000
Q2 2018 Aug 03, 2018	SELL	$119.4 - $131.76 $22,805 - $25,166	-191 Reduced 3.92%	4,681 $568,000
Q1 2018 May 08, 2018	SELL	$125.1 - $148.14 $25,020 - $29,627	-200 Reduced 3.94%	4,872 $624,000
Q4 2017 Jan 23, 2018	SELL	$131.22 - $143.62 $19,683 - $21,543	-150 Reduced 2.87%	5,072 $709,000
Q3 2017 Oct 05, 2017	BUY	$129.47 - $135.38 $676,092 - $706,954	5,222	5,222 $679,000

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $419B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelman Lazarov, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kelman Lazarov, Inc. with notifications on news.

Account

Kelman Lazarov, Inc. Johnson & Johnson Transaction History